Fabiflu is for mild to moderate cases of COVID-19. Covifor and Cipremi Covifor and Cipremi are versions of USFDA-approved Remdesivir.
indica News Bureau- Gilead Sciences, the US drug maker has signed a non-exclusive voluntary licensing agreements with three Indian pharmaceutical companies — Hyderabad-based Hetero Labs, Mumbai-headquartered Cipla, and Noida-based Jubilant Life Sciences to manufacture and sell the anti-viral drug to people who have severe COVID-19 infection. US-based Mylan which has a strong base in India […]
Indica News Bureau – Mumbai-based drug major Cipla could be the first company in India to manufacture new drugs for Covid-19 The company is known for creating several innovations for respiratory and flu therapy. Cipla promoter Yusuf Hamied says that they consider it their national duty to put all their resources to invent drugs for […]